Page 2 - Glp1

India gets cheap GLP-1 drugs: What you must know before trying it

India's 'cheap Ozempic moment' is here as semaglutide prices fall sharply, but doctors warn against misuse and stress careful evaluation before using these weight-loss injections

Govt intensifies checks on illegal sale, misuse of GLP-1 weight-loss drugs

As cheaper GLP-1 weight-loss drugs flood India after patent expiry, the government has intensified surveillance to curb illegal sales, misleading promotion, and unsafe use without medical supervision

What happens after stopping GLP-1 drugs like Ozempic? Study reveals

A large real-world study finds patients stopping semaglutide or tirzepatide may not regain as much weight as expected, aided by treatment switches, restarts, and lifestyle support

Fake obesity drugs are booming globally: Lancet report raises alarm

A Lancet report warns counterfeit weight-loss injections like Ozempic and Mounjaro are spreading globally, driven by high demand and prices, raising serious risks for patients

CDSCO asks drugmakers to stop GLP-1 obesity awareness ad campaigns

Drug regulator warns pharma companies that obesity awareness drives linked to GLP-1 drugs could amount to misleading promotion of prescription medicines

Indian CDMOs expand capacity as demand for complex drug work rises

Indian CDMOs are expanding manufacturing capacity and investing in advanced technologies as global pharma companies increasingly outsource complex drug development and manufacturing work

GLP-1 drugs may fight addiction across every major substance: Study

Patients on GLP-1 drugs report losing cravings for addictions, ranging from opioids to gambling, prompting researchers to examine whether these diabetes and obesity medicines can curb addiction

GLP-1 drugs: How to lose the fat without losing your muscle, shares expert

A US-based gastroenterologist warns that while GLP-1 drugs help shed kilos, they may also reduce lean muscle mass if not paired with strength training and adequate protein intake

Ozempic and other weight-loss drugs: Cost, risks, who really needs them

As Ozempic and other GLP-1 drugs gain popularity, experts explain who qualifies, the real health benefits, potential risks, side effects, and why supervision is critical

Biopharma Shakti shows India focusing on being biopharma hub: Biocon's Shaw

After cutting debt and raising $1 billion, Biocon sharpens its biosimilars and GLP-1 play, betting on scale, regulatory reform and AI to power the next growth phase

Ozempic may slow arthritis progression beyond weight loss, study finds

A new study finds semaglutide drugs like Ozempic may slow osteoarthritis by directly improving cartilage health, with benefits seen even when weight loss is not the driver

Serena Williams reveals GLP-1 weight loss journey in Super Bowl 2026 ad

The tennis legend says she lost 15 kg using a GLP-1 medication after struggling with post-pregnancy weight, revealing the journey in a Super Bowl 2026 ad for telehealth firm Ro

India-EU trade deal likely to help GLP-1 therapies become cheaper

India-EU FTA to lower tariffs on pharma, potentially making GLP-1 therapies like semaglutide cheaper and boosting adoption among diabetics in India

Gene therapy for weight loss: Can one shot replace lifelong GLP-1 drugs?

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that aims to trigger long-term weight loss by programming the pancreas to produce more GLP-1 hormone

GLP-1 drugs and pregnancy: Why stopping may trigger hidden risks

As GLP-1 use rises, research and experts warn the post-drug phase may be a critical window for weight gain, metabolic instability and unexpected pregnancies

Weight regain after weight loss drugs is common; here's how to prevent it

Many people regain weight after stopping Ozempic and similar drugs. Expert shares why it happens and the practical steps needed to maintain weight in the long term

Why weight returns fast after stopping obesity drugs? Homeostasis explained

Here's how homeostasis, hormones and obesity drugs affect why lost weight often returns faster than expected

Stopping Ozempic or Mounjaro? The weight may come back faster than you think

New research shows people regain weight far faster after stopping obesity drugs than after dieting, with benefits fading quickly and raising questions about how long GLP-1 medicines need to be taken

How 2025 marked a turning point for health science and innovation

From GLP-1 drugs and personalised cancer vaccines to longevity experiments and regenerative therapies, 2025 marked a year when scientific breakthroughs reshaped healthcare and medicine

From fibremaxxing to GLP-1s: What were India's top health trends in 2025?

From fibremaxxing and longevity clinics to GLP-1 drugs, AI hospitals and workplace mental health, 2025 reshaped how India talks about prevention, ageing and wellbeing